Medical Imaging Reagents Market

Medical Imaging Reagent Market is valued at USD 11.56 Billion in 2020 and is expected to reach USD 16.48 Billion by 2027 with a CAGR of 5.2% over the forecast period.

Global Medical Imaging Reagent Market: Global Size, Trends, Competitive, Historical & Forecast Analysis 2021-2027, Rising prevalence of cardiovascular & neurological diseases and increasing healthcare services as well as improving healthcare infrastructure are some of the major factors driving the growth of Global Medical Imaging Reagent Market.

Scope of Global Medical Imaging Reagent Market Report:

Medical imaging reagent is described as a substance administered to patients before a medical imaging procedure. They are used to improve contrast in images of the inside of the body found using X-rays, γ-rays, and radioactive particles. The kinds of imaging reagents utilized by the biological and medical imaging reagents market include fluorescent proteins, fluorescent probes and dyes, magnetic resonance imaging, nanoparticles, ultrasound & X-ray contrast reagents, and imaging radiopharmaceuticals. Medical imaging reagents are considered as chemicals applied to picture structures or organs, hence encouraging physicians to healthier analyze and identify diseases.

These composites are generally applicable in recognition and imaging technologies in the therapeutic & healthcare industry and numerous life science-associated fields such as medicine, biotechnology, and pharmaceutical research. The majorly used imaging technologies include; magnetic resonance imaging (MRI), computed tomography, X-ray, and others. Imaging technologies analyze the morphology and anatomy of the human body, but these techniques cannot detect any variations at the molecular level. The idea of medical imaging started in 1895.

COVID-19 pandemic has influenced the medical imaging reagent market adversely. The lockdown led to limitations, disruption, challenges, and changes in the medical imaging reagent market worldwide. Medical imaging reagents are utilized in medical imaging for analysis of clinical situations. Thus, the restricted availability of medical care for situations other than COVID-19 across the world has impacted several medical imaging processes performed worldwide in a negative approach. Due to social distancing, there is limited healthcare staff across the world which also negatively impacts the market growth.

Medical Imaging Reagent Companies:

Global Medical Imaging Reagent market reports cover prominent players like Bayer AG, Bracco SpA, Cardinal Health, Eli Lilly and Company, General Electric Company (GE Healthcare), Lantheus Holdings, Inc., LI-COR Biosciences Inc., Merck KGaA (Sigma-Aldrich), PerkinElmer, Inc., and Thermo Fisher Scientific Inc. and others.

Global Medical Imaging Reagent Market Segmentation:

The Global Medical Imaging Reagent Market is segmented on the basis on class, technology, and region & country level. Based on class, the medical imaging reagent market is classified as contrast reagents, optical reagents, nuclear reagents. Based on technology, the medical imaging reagent market is segmented into nanoparticles, fluorescent dyes & probes, radiopharmaceuticals, fluorescent proteins, and quantum dots.

By Class:

• Contrast Reagents
• Optical Reagents
• Nuclear Reagents

By Technology:

• Nanoparticles
• Fluorescent Dyes & Probes
• Radiopharmaceuticals
• Fluorescent Proteins
• Quantum Dots

The regions covered in this Medical Imaging Reagent market report are North America, Europe, Asia-Pacific, and Rest of the World. Based on a country level, the market of Medical Imaging Reagent is sub-divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

News: Thermo Fisher Scientific Launched CytoVista Tissue Clearing Reagents for 3D Tissue Imaging

On February 21^st, 2019; Thermo Fisher Scientific announced the launch of their CytoVista tissue clearing reagents which are designed for use with both 3D cell culture models as well as whole tissues. The CytoVista tissue clearing workflow is compatible with most fluorophores, including fluorescent proteins that are detected with common fluorescent imaging instruments, such as wide-field microscopes, high content analyzers, confocal microscopes, and light-sheet microscopes. The CytoVista portfolio is designed to allow for easy-to-use tissue clearing and is comprised of several kits for first-time users that allow any researcher to adopt tissue clearing into their research for a few hundred dollars.  With the CytoVista products, a researcher can easily transition from traditional 2D histology towards imaging their tissues in 3D to get a more complete understanding of complex tissues and heterogeneously expressed biomarkers. The CytoVista tissue clearing technology sufficiently clears tissue for 3D fluorescent imaging, but unlike other clearing techniques such as CLARITY, Scale, BABB and i/3/uDISCO does not significantly change the tissue morphology.

Global Medical Imaging Reagent Market Dynamics:

Several factors are contributing to the growth of the medical imaging reagent market across the world including such as; rising prevalence of cardiovascular & neurological diseases and cancer, growing awareness related to medical imaging, increasing geriatric population. Cardiovascular diseases are one of the prominent reasons for deaths throughout the globe. For instance; according to the World Health Organization, the incidences of cardiovascular diseases are projected to be 17.9 million lives every year. Approximately 17.9 million people cause death every year due to cardiovascular diseases.

Additionally, according to the American Health Organization 2019, the total number of cases of neurological diseases is nearly 533,172 deaths with 213,129 men and 320,043 women. There were around 32.9 deaths per 100,000 population in the states of America. To prevent the growing deaths of people all over the world, medical imaging is incredibly necessary. This detects the changes in the body, analyzes the morphology, detects the disease, and helps to early diagnosis of disease. Thus, the demand for medical imaging reagents increases all over the world.

In addition, increasing healthcare services and improving healthcare infrastructure is another factor supplementing the growth of the medical imaging reagent market across the world. For instance; the U.S. expanded more than 16.9 percent of gross domestic product (GDP) on health care according to The Commonwealth Fund 2019. Per capita, health spending exceeded nearly $10,000 in the U.S. up to two times higher than in other countries. Likewise, Part B of Medicare encompasses about 80.0% of the Medicare-approved amount for medically needed emergency and non-emergency ambulance services.

However, a lack of imaging reagent suppliers and strict government guidelines are anticipated to obstruct the growth of the medical imaging reagent market. Despite this, rapid development throughout several technology fields may offer lucrative opportunities for the further growth of the global medical imaging reagent market.

Global Medical Imaging Reagent Market Regional Analysis–

Geographically, North America is expected to capture the largest share of the global medical imaging reagent market owing to the growing demand for functional imaging diagnostic and technologies, presence of key players and highly advanced healthcare infrastructure in this region. The increasing prevalence of chronic diseases is one of the major factors propelling the growth of the medical imaging reagent market in North America.

For instance; according to the Centers for Disease Control and Prevention 2020, 6 in 10 adults in the US have a chronic disease. Up to 868,000 Americans die of stroke, heart disease, or other cardiovascular diseases each year. More than 1.6 million people are diagnosed with cancer, and approximately 600,000 dies from it in the United States each year. The cost of cancer care remains to rise in Patients with chronic diseases need to undergo diagnosis to cure the disease which radically increase the demand for medical imaging reagents. The Asia Pacific is expected to witness a fastest growth the global medical imaging reagent market due to the increasing prevalence of chronic diseases and rising geriatric population in this region.

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy

Asia Pacific

• China
• Japan
• India
• Southeast Asia

Latin America

• Brazil
• Mexico

The Middle East and Africa

• GCC
• Africa
• Rest of the Middle East and Africa

Key Benefits of Medical Imaging Reagent Market Report–

• Global Medical Imaging Reagent market report covers in-depth historical and forecast analysis.
• Global Medical Imaging Reagent market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Medical Imaging Reagent Companies, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global Medical Imaging Reagent market report helps to identify opportunities in the marketplace.
• Global Medical Imaging Reagent market report covers extensive analysis of emerging trends and competitive landscape.

Frequently Asked Questions (FAQ) :